Deutsche Bank Research chart shows the top market risks cited by investors versus a year ago.
China’s latest restrictions mark “several firsts in the trade war,” researchers say.
Investors might be well served by expanding beyond the S&P 500.
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts said
One analyst is “very bullish” on Micron’s stock ahead of what could be a mixed report on Wednesday. But he cautioned that a post-earnings stock bump might not last long.
S&P services survey shows business is booming
The newest member of the trillion-dollar market-cap club is looking ahead to a “likely sharp new product ramp” in the second half of 2025, according to an analyst.
Yields on U.S. government debt dropped from their highest levels in a few weeks on Monday as buyers emerged during the Asian, European and early U.S. sessions.
